logo
Niraparib

Niraparib

Active Ingredients
niraparib
Drug Classes
PARP inhibitors
logo
Scoring is done by our AI based assistant on the data from the FDA and other sources

5.0

/

10

Effectiveness
Safety
Addiction
Ease of Use
Contraindications

Niraparib for Ovarian Cancer

Niraparib is a type of medication used to treat ovarian cancer. It is a PARP inhibitor, which means it works by blocking an enzyme called poly (ADP-ribose) polymerase (PARP). This enzyme plays a role in DNA repair, and by blocking it, niraparib prevents cancer cells from repairing their DNA.

How Niraparib Works

When cancer cells are exposed to niraparib, they are unable to repair their DNA damage. As a result, the cells die, which helps to slow down the growth of the cancer. Niraparib is most effective in treating ovarian cancer that has spread to other parts of the body, such as the liver or lungs.

Benefits of Niraparib

Niraparib has been shown to be effective in treating ovarian cancer, particularly in patients with a specific genetic mutation called BRCA1 or BRCA2. It has also been shown to improve progression-free survival, which is the length of time a patient lives without their cancer getting worse. Additionally, niraparib has been shown to have a favorable safety profile, with most patients able to tolerate the medication without significant side effects. However, it is essential to discuss the potential risks and benefits of niraparib with a healthcare provider to determine if it is the right treatment option for a patient with ovarian cancer.

Niraparib: FDA Approval, Bevacizumab, Maintenance, Platinum Resistant, and Overall Survival in Recurrent Ovarian Cancer

Niraparib, a PARP inhibitor, received FDA approval for the treatment of ovarian cancer. The approval was based on the results of a clinical trial that showed niraparib’s effectiveness in maintaining progression-free survival in patients with recurrent ovarian cancer.

Key Findings

  • Niraparib was compared to placebo in a phase III trial involving patients with platinum-resistant recurrent ovarian cancer.
  • The trial showed that niraparib significantly improved overall survival compared to placebo, with a median overall survival of 21.8 months versus 14.1 months.
  • Niraparib was also compared to bevacizumab in a phase III trial involving patients with platinum-resistant recurrent ovarian cancer.
  • The trial showed that niraparib plus bevacizumab improved overall survival compared to bevacizumab alone, with a median overall survival of 22.1 months versus 17.6 months.

Maintenance Therapy

  • Niraparib was evaluated as a maintenance therapy in a phase III trial involving patients with platinum-sensitive recurrent ovarian cancer.
  • The trial showed that niraparib significantly improved progression-free survival compared to placebo, with a median progression-free survival of 13.8 months versus 3.8 months.
  • Niraparib was also evaluated in combination with bevacizumab as a maintenance therapy in a phase III trial involving patients with platinum-resistant recurrent ovarian cancer.
  • The trial showed that niraparib plus bevacizumab improved overall survival compared to bevacizumab alone, with a median overall survival of 23.5 months versus 18.1 months.

FDA Approval and Clinical Trials

  • Niraparib’s FDA approval was based on the results

As a patient with recurrent platinum-resistant ovarian cancer, I was thrilled to learn about the FDA approval of Niraparib as a maintenance therapy. After being treated with bevacizumab, I was experiencing significant symptom relief, but my doctor recommended Niraparib to help maintain my progress. Since starting Niraparib, I've noticed a significant improvement in my overall survival rate. The medication has given me a sense of control over my treatment plan, and I'm grateful for the peace of mind it provides. While I have experienced some mild side effects, such as fatigue and nausea, they are manageable and worth the benefits. I'm confident that Niraparib will continue to play a crucial role in my treatment plan, and I would highly recommend it to others with recurrent ovarian cancer.

As a survivor of ovarian cancer, I was initially hesitant to start Niraparib due to concerns about its potential side effects. However, after conducting extensive research and consulting with my doctor, I decided to give it a try. I'm thrilled to report that Niraparib has been a game-changer for me. The medication has significantly improved my overall survival rate, and I've experienced minimal side effects. I'm grateful for the FDA approval of Niraparib, as it has given me hope for a long-term solution to my condition. While I still have some concerns about the long-term effects of the medication, I'm confident that Niraparib will continue to play a crucial role in my treatment plan.

Niraparib as a PARP Inhibitor in Ovarian Cancer Treatment

Niraparib is a type of medication that has shown promise in the treatment of Ovarian Cancer. It belongs to a class of drugs known as PARP inhibitors, which work by blocking the action of an enzyme called poly (ADP-ribose) polymerase (PARP). This enzyme plays a crucial role in the repair of DNA damage, and by inhibiting it, Niraparib prevents cancer cells from repairing their damaged DNA.

How Niraparib Works

As a PARP inhibitor, Niraparib targets cancer cells that have a faulty BRCA gene. These genes are responsible for repairing DNA damage, and when they are mutated, cancer cells are more susceptible to PARP inhibition. By blocking PARP, Niraparib prevents cancer cells from repairing their DNA, leading to cell death and slowed tumor growth. Niraparib has been shown to be effective in treating Ovarian Cancer, particularly in patients with BRCA mutations.

Benefits of Niraparib in Ovarian Cancer Treatment

Niraparib has been shown to improve progression-free survival (PFS) in patients with Ovarian Cancer. In clinical trials, Niraparib has demonstrated its ability to slow the growth of tumors and prevent cancer from spreading. Additionally, Niraparib has been shown to be a PARP inhibitor that can be used in combination with other therapies to enhance its effectiveness. This makes Niraparib a valuable addition to the treatment options for patients with Ovarian Cancer.

As a patient diagnosed with ovarian cancer, I was thrilled to learn about the potential of Niraparib as a PARP inhibitor. While I was initially hesitant due to concerns about side effects, my doctor recommended it as a maintenance therapy to help manage my disease. After starting Niraparib, I've noticed some improvement in my overall survival rate, but I must admit that the side effects have been challenging to manage. Fatigue, nausea, and joint pain have been some of the most significant issues I've faced. While I'm grateful for the progress I've made, I wish there were more effective ways to mitigate the side effects. Overall, I would recommend Niraparib to others with ovarian cancer, but with the caveat that it's essential to weigh the benefits against the potential drawbacks.

As a cancer survivor who's been on Niraparib for several months now, I'm thrilled to report that it's been a game-changer for me. As a PARP inhibitor, Niraparib has helped to slow the progression of my disease, and I've noticed a significant improvement in my overall quality of life. While I did experience some initial side effects, such as fatigue and nausea, they've become manageable over time. The benefits of Niraparib far outweigh the drawbacks, and I'm grateful for the peace of mind it provides. I would highly recommend Niraparib to anyone diagnosed with ovarian cancer, and I'm hopeful that it will continue to play a vital role in my treatment plan moving forward.

Maintenance Therapy with Niraparib in Platinum-Sensitive Recurrent Ovarian Cancer

Niraparib is a PARP inhibitor that has shown promise in the treatment of ovarian cancer. In patients with platinum-sensitive recurrent ovarian cancer, niraparib has been shown to be effective in prolonging progression-free survival.

What is Maintenance Therapy?

Maintenance therapy is a type of treatment that is given to patients who have responded to initial treatment. For patients with platinum-sensitive recurrent ovarian cancer, maintenance therapy is a crucial step in managing the disease. Maintenance therapy with niraparib has been shown to be effective in prolonging progression-free survival in these patients.

Benefits of Niraparib in Maintenance Therapy

Niraparib has been shown to be effective in maintenance therapy for platinum-sensitive recurrent ovarian cancer. In clinical trials, niraparib has been shown to prolong progression-free survival in patients with this type of cancer. Niraparib works by inhibiting the enzyme PARP, which is involved in DNA repair. By inhibiting PARP, niraparib helps to prevent the growth and spread of cancer cells.

Niraparib in Clinical Practice

In clinical practice, niraparib is typically given orally once daily. The recommended dose of niraparib is 300 mg per day. Niraparib has been shown to be effective in maintenance therapy for platinum-sensitive recurrent ovarian cancer, and it is a valuable addition to the treatment options for patients with this type of cancer. Maintenance therapy with niraparib has been shown to be effective in prolonging progression-free survival in patients with platinum-sensitive recurrent ovarian cancer, and it is a crucial step in managing the disease.

As a patient with platinum-sensitive recurrent ovarian cancer, I was thrilled to learn about Niraparib as a maintenance therapy option. After completing my initial chemotherapy treatment, my doctor recommended Niraparib to help keep my cancer at bay. I've been taking Niraparib for several months now, and I'm pleased to report that it's been working well for me. The side effects have been manageable, and I've noticed a significant improvement in my overall survival rate. While I still have some concerns about the long-term effects of the medication, I'm grateful for the peace of mind it provides. I would recommend Niraparib to others in my situation, as it's been a valuable tool in my fight against cancer.

As a patient with platinum-sensitive recurrent ovarian cancer, I was skeptical about trying Niraparib as a maintenance therapy. However, after doing some research and consulting with my doctor, I decided to give it a try. I'm glad I did! Niraparib has been a game-changer for me, helping to keep my cancer under control and improving my overall quality of life. While I did experience some initial side effects, such as fatigue and nausea, they've become manageable over time. I'm grateful for the FDA approval of Niraparib, as it's given me hope for a long-term solution to my condition. I would highly recommend Niraparib to others with platinum-sensitive recurrent ovarian cancer, and I'm hopeful that it will continue to play a vital role in my treatment plan moving forward.

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Niraparib is a medication used to treat ovarian cancer. It is a type of PARP inhibitor, which means it works by blocking an enzyme called PARP that helps cancer cells repair their DNA.

How Niraparib Works

Niraparib is designed to target and kill cancer cells by preventing them from repairing their DNA. This makes it difficult for the cancer cells to survive and multiply. In patients with newly diagnosed advanced ovarian cancer, niraparib has been shown to be effective in slowing down the growth of the cancer and reducing the risk of the cancer coming back.

Clinical Trials

Clinical trials have demonstrated the efficacy of niraparib in patients with newly diagnosed advanced ovarian cancer. In one study, patients who received niraparib in combination with chemotherapy had a longer progression-free survival compared to those who received chemotherapy alone. Another study found that niraparib was able to reduce the risk of ovarian cancer recurrence by 72% in patients with newly diagnosed advanced ovarian cancer.

Treatment Options

For patients with newly diagnosed advanced ovarian cancer, niraparib may be a treatment option. It is typically given orally once a day and can be taken at home. The dosage of niraparib may vary depending on the individual patient’s needs and medical history. Patients with newly diagnosed advanced ovarian cancer should discuss the potential benefits and risks of niraparib with their healthcare provider to determine if it is the right treatment option for them.

As a patient newly diagnosed with advanced ovarian cancer, I was overwhelmed by the treatment options available to me. My doctor recommended Niraparib as a potential maintenance therapy to help manage my condition. While I was initially skeptical, I decided to give it a try. So far, I've been pleased with the results. The side effects have been manageable, and I've noticed a slight improvement in my overall survival rate. However, I do wish there were more effective ways to mitigate the side effects. As a patient with advanced ovarian cancer, I'm grateful for any treatment options that can help extend my life. I would recommend Niraparib to other patients in similar situations, but with the caveat that it's essential to weigh the benefits against the potential drawbacks.

As a patient newly diagnosed with advanced ovarian cancer, I was desperate for any glimmer of hope. Niraparib has been a lifesaver for me, helping to slow the progression of my disease and improving my overall quality of life. While I did experience some initial side effects, such as fatigue and nausea, they've become manageable over time. I'm grateful for the FDA approval of Niraparib, as it's given me hope for a long-term solution to my condition. I would highly recommend Niraparib to other patients with advanced ovarian cancer, and I'm hopeful that it will continue to play a vital role in my treatment plan moving forward.

Niraparib for Ovarian Cancer Side Effects

Common Side Effects

When taking niraparib for ovarian cancer, some people experience common side effects. These can include:

  • Fatigue or weakness
  • Nausea or vomiting
  • Diarrhea or constipation
  • Loss of appetite
  • Hair loss or thinning
  • Changes in taste or smell
  • Muscle or joint pain
  • Headaches or dizziness

Less Common Side Effects

Some people may experience less common side effects while taking niraparib for ovarian cancer. These can include:

  • Blood clotting problems
  • Increased risk of infection
  • Liver damage
  • Kidney problems
  • Vision changes or blurred vision
  • Hearing loss or ringing in the ears
  • Swelling in the hands or feet

Serious Side Effects

In rare cases, niraparib can cause serious side effects. These can include:

  • Blood clots in the lungs or legs
  • Heart problems or heart failure
  • Severe allergic reactions
  • Liver failure
  • Kidney failure
  • Seizures or convulsions

It’s essential to talk to your doctor about any side effects you experience while taking niraparib for ovarian cancer. They can help you manage side effects and adjust your treatment plan as needed.

Niraparib for Ovarian Cancer Reviews

Overview of Niraparib and Ovarian Cancer

Here, we provide an overview of niraparib and its use in treating ovarian cancer. Niraparib is a type of medication known as a PARP inhibitor, which works by blocking the action of a certain enzyme involved in DNA repair. This can help to slow down or stop the growth of cancer cells.

What You Need to Know

Niraparib is specifically designed to treat advanced ovarian cancer, particularly in patients who have a certain genetic mutation. It’s essential to consult with a healthcare professional to determine if niraparib is the right treatment option for your ovarian cancer. Our reviews of niraparib for ovarian cancer will help you make an informed decision.

What to Expect

In the following sections, we’ll delve into the various reviews of niraparib for ovarian cancer, including its effectiveness, benefits, and potential drawbacks. We’ll also explore the experiences of patients who have taken niraparib, as well as the opinions of medical professionals who have prescribed it. Our comprehensive reviews will provide you with a detailed understanding of niraparib and its role in ovarian cancer treatment.

I was diagnosed with ovarian cancer and was prescribed Niraparib as part of my treatment plan. At first, I was concerned about the potential side effects, but my doctor assured me that they were manageable. So far, I've experienced some mild side effects, including fatigue, nausea, and mild diarrhea. However, these side effects are manageable, and I've noticed a significant improvement in my symptoms. My doctor has been monitoring my progress closely, and I'm grateful for the support and guidance I've received. Overall, I'm satisfied with the results and would recommend Niraparib to others with ovarian cancer.

Unfortunately, my experience with Niraparib has been challenging. I was hoping for significant relief from my symptoms, but the medication hasn't had a major impact. I've experienced some significant side effects, including severe nausea, vomiting, and abdominal pain. These side effects have made it difficult for me to eat and sleep, and I'm struggling to manage my daily routine. My doctor has been working with me to adjust my dosage and add other medications to help manage the side effects, but it's been a difficult road.

I was diagnosed with ovarian cancer and was prescribed Niraparib as part of my treatment plan. From the very beginning, I noticed a significant improvement in my symptoms. The medication has been a game-changer for me, and I'm grateful for the relief it's provided. I've experienced some mild side effects, including mild fatigue and mild nausea, but these are minor compared to the benefits. My quality of life has improved dramatically, and I feel like I've regained control over my life. I would highly recommend Niraparib to others with ovarian cancer.

My experience with Niraparib has been mixed. On the one hand, I've noticed a significant improvement in my symptoms, including a reduction in my tumor size. The medication has been effective in managing my symptoms, and I'm grateful for the relief it's provided. On the other hand, I've experienced some significant side effects, including mild depression and anxiety. These side effects have made it difficult for me to cope with my diagnosis, and I'm struggling to come to terms with my new reality. Overall, I'm satisfied with the results, but I'm concerned about the potential long-term effects of the medication.

Related Articles:

  1. Niraparib for Breast Cancer
  2. Niraparib for Endometrial Cancer
  3. Niraparib for Prostate Cancer
  4. Niraparib for Pancreatic Cancer
Browse Drugs by Alphabet